A vaccine being developed by Merck and NewLink was shown to be 100 percent effective, but does this mean they'll make big bucks?» Read More
California has seen a rush of people health insurance, but it will have a tougher time with the remaining uninsured during Obamacare's next enrollment.
Here's the problem with a recent attempt by the government to make health costs more transparent, says the CEO of Change Healthcare.
Many can't afford Obamacare, and it doesn't fix the underlying causes of high health-care costs, Aetna Chairman and CEO Mark Bertolini tells CNBC.
The Obamacare program of expanding Medicaid is helping hospital bottom lines in many states—but looming cuts could snatch some of that money back.
FedEx said it would fight any additional charges if they are brought. FedEx is due back in court Sept. 24 in San Francisco for a status conference.
Pfizer CEO Ian Read also says a potential U.S. tax holiday would be only a temporary solution.
Amgen posted higher-than-expected profit and said it would cut 12 to 15 percent of its workforce and close two plants.
Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.
Merck reported better-than-expected quarterly results, with sales of newer drugs mostly offsetting declining sales of drugs facing generic competition.
While a big court decision threatens billions in Obamacare subsidies, many people who benefit from that money are unaware they even get it.
A new hepatitis drug could be significant for Arrowhead Research, CEO Chris Anzalone says.
Slower growth in healthcare spending is shoring up the funding outlook for the federal Medicare program that covers hospital bills for the elderly.
Pfizer's vulnerability to cheap generics and its weak roster of experimental medicines will be on display Tuesday, when the company reports earnings.
Reckitt Benckiser plans to spin off its heroin-addiction treatment in the next 12 months as sales slide under pressure from rival versions.
Hospira could use an acquisition of the Danone business to redomicle its tax headquarters in France in a deal known as a tax inversion.
Additional rules and enforcement from federal agencies have a majority of employers worried about how to run their firms.
Big variations in price from provider to provider could be adding to your bills—even if you're insured.
Surely Congress didn't mean to include a "poison pill" for the Affordable Care Act when it passed it, says law professor Tim Jost.
States might need to spend only hundreds of dollars or less to protect Obamacare subsidies for residents currently enrolled in HealthCare.gov plans.
GlaxoSmithKline faces new corruption allegations in Syria, where it has been accused of paying bribes to secure business.
Get the best of CNBC in your inbox